Avantor, Inc. $AVTR Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lessened its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 97.1% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 106,070 shares of the company’s stock after selling 3,514,385 shares during the period. Assenagon Asset Management S.A.’s holdings in Avantor were worth $832,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Royal Bank of Canada lifted its position in shares of Avantor by 104.3% during the 1st quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock worth $3,302,000 after buying an additional 104,022 shares during the last quarter. Empowered Funds LLC grew its position in shares of Avantor by 40.3% in the 1st quarter. Empowered Funds LLC now owns 17,659 shares of the company’s stock valued at $286,000 after buying an additional 5,075 shares during the last quarter. Cetera Investment Advisers grew its position in shares of Avantor by 40.2% in the 2nd quarter. Cetera Investment Advisers now owns 40,289 shares of the company’s stock valued at $542,000 after buying an additional 11,543 shares during the last quarter. Quantbot Technologies LP acquired a new stake in Avantor during the 2nd quarter worth $232,000. Finally, Arrowstreet Capital Limited Partnership raised its stake in Avantor by 214.9% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 124,076 shares of the company’s stock worth $1,670,000 after acquiring an additional 84,679 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Price Performance

Avantor stock opened at $10.29 on Friday. Avantor, Inc. has a 12 month low of $7.26 and a 12 month high of $15.93. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17. The business has a 50 day simple moving average of $8.83 and a 200-day simple moving average of $9.46. The stock has a market capitalization of $7.03 billion, a PE ratio of -12.71, a price-to-earnings-growth ratio of 5.81 and a beta of 0.94.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.54 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. Avantor’s quarterly revenue was up .0% on a year-over-year basis. During the same period last year, the firm posted $0.23 EPS. Equities analysts predict that Avantor, Inc. will post 0.79 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on AVTR shares. Zacks Research raised shares of Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, April 30th. Wolfe Research cut Avantor to an “underperform” rating and set a $7.00 target price on the stock. in a research report on Monday, June 1st. Barclays boosted their target price on Avantor from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, June 24th. Royal Bank Of Canada began coverage on Avantor in a research report on Thursday, May 14th. They issued a “sector perform” rating and a $9.00 target price for the company. Finally, Sanford C. Bernstein began coverage on Avantor in a research note on Friday, June 26th. They issued a “market perform” rating and a $10.50 price objective for the company. Two research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Avantor presently has an average rating of “Reduce” and a consensus target price of $10.47.

Insider Buying and Selling at Avantor

In other news, Director Gregory T. Lucier bought 10,000 shares of the stock in a transaction dated Friday, May 8th. The shares were acquired at an average price of $8.32 per share, with a total value of $83,200.00. Following the completion of the acquisition, the director directly owned 60,000 shares in the company, valued at approximately $499,200. The trade was a 20.00% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Simon Dingemans purchased 25,000 shares of the company’s stock in a transaction dated Friday, May 1st. The shares were purchased at an average price of $8.14 per share, for a total transaction of $203,500.00. Following the completion of the purchase, the director owned 25,000 shares of the company’s stock, valued at approximately $203,500. This trade represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.28% of the stock is currently owned by company insiders.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.